Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: A systematic review and meta-analysis

This publication has 23 references indexed in Scilit:

• Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia: Abstracted from: Zhu Q, Tan DCL, Samuel M, Chan ESY, Linn YC. Fludarabine in comparison to alkylator-based regimen as induction therapy for chronic lymphocytic leukaemia: A systematic review and meta-analysis. Leukaemia Lymphoma 2004; 45:2239–45.
  Cancer Treatment Reviews, 2005
• Fludarabine in Comparison to Alkylator-based Regimen as Induction Therapy for Chronic Lymphocytic Leukemia: A Systematic Review and Meta-analysis
  Leukemia & Lymphoma, 2004
• ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia
  New England Journal of Medicine, 2004
• ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic Leukemia
  New England Journal of Medicine, 2003
• Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia
  Leukemia, 2002
• Evaluating treatment strategies in chronic lymphocytic leukemia
  Journal of Clinical Epidemiology, 2001
• Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia
  New England Journal of Medicine, 2000
• Chemotherapeutic Options in Chronic Lymphocytic Leukemia: a Meta-analysis of the Randomized Trials
  JNCI Journal of the National Cancer Institute, 1999
• Chronic Lymphocytic Leukemia
  New England Journal of Medicine, 1995
• Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group
  American Journal of Hematology, 1988